Great Basin Withdraws Plan to Raise $8M

Jan 20, 2017

NEW YORK (GenomeWeb) – Great Basin Scientific announced today that it will no longer pursue a previously announced plan to raise $8 million in equity financing.

The firm has asked the US Securities and Exchange Commission to withdraw its S-1 registration statement connected to the planned financing, as a result.

Great Basin had intended to raise additional funds when it entered into a convertible note financing last July, saying it anticipated needing the additional funds to finance operations in late 2016 through early 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Breaking News

Featured White Papers

Benchmarking of the Microsart AMP Mycoplasma Kit with Products of Two Other Suppliers

Oct

24

Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Dec

02

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

This webinar will discuss how Moffitt Cancer Center  has implemented a new capture-based application to accurately assess myeloid malignancies  by detecting complex variants in challenging genes  in a single experiment. 

Menu